Publicacións nas que colabora con Fernando Cordido Carballido (37)

2017

  1. Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): A Pituitary Society Statement

    Pituitary, Vol. 20, Núm. 5, pp. 489-498

2015

  1. Effect of oral glucose administration on rebound growth hormone release in normal and obese women: The role of adiposity, insulin sensitivity and ghrelin

    PLoS ONE, Vol. 10, Núm. 3

2013

  1. Changes in hypothalamic expression of the Lin28/let-7 system and related MicroRNAs during postnatal maturation and after experimental manipulations of puberty

    Endocrinology, Vol. 154, Núm. 2, pp. 942-955

2011

  1. Ghrelin and lipid metabolism: Key partners in energy balance

    Journal of Molecular Endocrinology, Vol. 46, Núm. 2, pp. 43-63

2010

  1. Influence of ghrelin and growth hormone deficiency on amp-activated protein kinase and hypothalamic lipid metabolism

    Journal of Neuroendocrinology, Vol. 22, Núm. 6, pp. 543-556

2009

  1. Central ghrelin regulates peripheral lipid metabolism in a growth hormone-independent fashion

    Endocrinology, Vol. 150, Núm. 10, pp. 4562-4574

  2. Vaspin and amylin are expressed in human and rat placenta and regulated by nutritional status

    Histology and Histopathology, Vol. 24, Núm. 8, pp. 979-990

2008

  1. Food intake regulating-neuropeptides are expressed and regulated through pregnancy and following food restriction in rat placenta

    Reproductive Biology and Endocrinology, Vol. 6

2006

  1. Effect of acute ghrelin administration on glycaemia and insulin levels in obese patients

    Diabetes, Obesity and Metabolism, Vol. 8, Núm. 5, pp. 555-560

2004

  1. Marked GH secretion after ghrelin alone or combined with GH-releasing hormone (GHRH) in obese patients

    Clinical Endocrinology, Vol. 61, Núm. 2, pp. 250-255

2003

  1. Comparison between insulin tolerance test, growth hormone (GH)-releasing hormone (GHRH), GHRH plus acipimox and GHRH plus GH-releasing peptide-6 for the diagnosis of adult GH deficiency in normal subjects, obese hypopituitary patients

    European Journal of Endocrinology, Vol. 149, Núm. 2, pp. 117-122

  2. Diagnosis of growth hormone deficiency after pituitary surgery: The combined acipimox/GH-releasing hormone test

    Clinical Endocrinology, Vol. 58, Núm. 2, pp. 156-162

  3. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients

    Clinical Endocrinology, Vol. 59, Núm. 4, pp. 431-436

2002

  1. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity

    Clinical Endocrinology, Vol. 56, Núm. 4, pp. 487-492

  2. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome

    Clinical Endocrinology, Vol. 57, Núm. 6, pp. 745-749

2001

  1. Effect of acute pharmacological modulation of plasma free fatty acids on GH secretion in acromegalic patients

    Clinical Endocrinology, Vol. 54, Núm. 4, pp. 509-513

1999

  1. Prevalence of pregnancy and postpartum thyroid dysfunction in a homogeneous population of Spain

    Gynecological Endocrinology, Vol. 13, Núm. 4, pp. 279-287

  2. Regulation of growth hormone secretion by signals produced by the adipose tissue

    Journal of Endocrinological Investigation, Vol. 22, Núm. 5 SUPPL., pp. 22-26

  3. Serum leptin levels in women throughout pregnancy and the postpartum period and in women suffering spontaneous abortion

    Clinical Endocrinology, Vol. 50, Núm. 2, pp. 211-216

  4. The use of growth hormone (GH) secretagogues in the diagnosis of GH deficiency in humans

    Growth Hormone and IGF Research